PGNX - Progenics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5388.9M
Enterprise Value 3286.59M
Trailing P/E N/A
Forward P/E 1-14.38
PEG Ratio (5 yr expected) 1-0.02
Price/Sales (ttm)23.90
Price/Book (mrq)3.38
Enterprise Value/Revenue 317.61
Enterprise Value/EBITDA 6-6.06

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-297.95%

Management Effectiveness

Return on Assets (ttm)-18.08%
Return on Equity (ttm)-63.58%

Income Statement

Revenue (ttm)16.27M
Revenue Per Share (ttm)0.22
Quarterly Revenue Growth (yoy)97.10%
Gross Profit (ttm)11.7M
EBITDA -47.3M
Net Income Avi to Common (ttm)-55.62M
Diluted EPS (ttm)-0.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)148.85M
Total Cash Per Share (mrq)1.76
Total Debt (mrq)46.55M
Total Debt/Equity (mrq)40.52
Current Ratio (mrq)9.51
Book Value Per Share (mrq)1.36

Cash Flow Statement

Operating Cash Flow (ttm)-50.49M
Levered Free Cash Flow (ttm)-33.52M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.57
52-Week Change 3-18.86%
S&P500 52-Week Change 3-1.47%
52 Week High 39.42
52 Week Low 34.24
50-Day Moving Average 35.09
200-Day Moving Average 36.88

Share Statistics

Avg Vol (3 month) 31.44M
Avg Vol (10 day) 31.8M
Shares Outstanding 584.54M
Float 77.75M
% Held by Insiders 10.40%
% Held by Institutions 186.31%
Shares Short (Nov 30, 2018) 49.52M
Short Ratio (Nov 30, 2018) 47.94
Short % of Float (Nov 30, 2018) 418.18%
Short % of Shares Outstanding (Nov 30, 2018) 411.26%
Shares Short (prior month Oct 31, 2018) 410.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A